The evolution of biomarkers in thyroid cancer-from mass screening to a personalized biosignature.
about
Thyroid malignant neoplasm-associated biomarkers as targets for oncolytic virotherapyFollicular thyroid cancer incidence patterns in the United States, 1980-2009Controversies in familial thyroid cancer 2014miRNA profiling, detection of BRAF V600E mutation and RET-PTC1 translocation in patients from Novosibirsk oblast (Russia) with different types of thyroid tumorsMicroRNA as a diagnostic tool in fine-needle aspiration biopsy of thyroid nodules.Cytologic and molecular diagnosis of thyroid cancers: is it time for routine reflex testing?The metabolomics and lipidomics window into thyroid cancer research.Bioinformatics Approach for Prediction of Functional Coding/Noncoding Simple Polymorphisms (SNPs/Indels) in Human BRAF GeneGalectin-1 is a diagnostic marker involved in thyroid cancer progression.Possible Impact of RET Polymorphism and Its Haplotypic Association Modulates the Susceptibility to Thyroid Cancer.Proteomic analysis reveals differential protein expression in variants of papillary thyroid carcinoma.
P2860
Q28071977-FA553652-330D-4112-8E89-66BBB803620AQ30543619-43100005-4518-4ABF-93A4-DD7F8272E961Q35233466-0FC98B88-EB7A-4B17-ACB2-89380450DBB2Q35951601-5C896FF1-D75F-4F8A-8686-27D24FF0E9C5Q36182811-3318854F-D5B6-41DC-B57A-BB030E514719Q37924711-F6030043-1DD2-4145-88AE-A9A2A4A0623BQ38996666-A0D0D2B5-9E93-444D-ACDA-26A129AADE1CQ39053829-A8441839-A9D8-4FC8-B2B4-4356160ED831Q41470048-652F33C2-8A4D-4640-81D1-D59D285DD8B1Q53595987-FEDA3B37-A2F6-441C-A13D-7B8ABD9233F8Q55085899-60452331-BE6D-4559-91CA-0802A5EF25D5
P2860
The evolution of biomarkers in thyroid cancer-from mass screening to a personalized biosignature.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The evolution of biomarkers in ...... o a personalized biosignature.
@en
The evolution of biomarkers in ...... o a personalized biosignature.
@nl
type
label
The evolution of biomarkers in ...... o a personalized biosignature.
@en
The evolution of biomarkers in ...... o a personalized biosignature.
@nl
prefLabel
The evolution of biomarkers in ...... o a personalized biosignature.
@en
The evolution of biomarkers in ...... o a personalized biosignature.
@nl
P2093
P2860
P356
P1433
P1476
The evolution of biomarkers in ...... o a personalized biosignature.
@en
P2093
Elliot J Mitmaker
Orlo H Clark
Raymon H Grogan
P2860
P304
P356
10.3390/CANCERS2020885
P577
2010-05-20T00:00:00Z